• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Sanofi Genzyme - Articles and news items

advanced prostate cancer

NICE recommends Jevtana for advanced prostate cancer

Industry news / 25 May 2016 / Victoria White, Digital Content Producer

Jevtana has been recommended in combination with other drugs as a treatment option for metastatic hormone-relapsed prostate cancer in England…

Sanofi makes huge investment in biologics

Sanofi makes huge investment in the future of biologics

Industry news / 19 April 2016 / Mandy Parrett, Editorial Assistant

Sanofi has announced plans to invest €300 million to expand its manufacturing and commercial capabilities at its site in Geel, Belgium.


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +